Pristyn Care is among the many Indian startups which have shrunk their workforce prior to now months.
GST representatives visited Pristyn Care’s workplace a couple of months earlier to ask questions concerning the actions of the agency.
Some 300-350 folks throughout departments had been let go by the Gurugram-based health-tech startup Pristyn Care within the final two months, in line with studies. Employees from the gross sales and tech departments have been impacted by the startup’s layoffs. The firm, nonetheless, claimed that it has solely let go of round 45 employees due to their poor efficiency.
“We have a radical efficiency evaluate strategy that helps us perceive the effectivity ranges throughout the board,” a Pristyn Care spokeswoman told Inc42. “We had to fire roughly 45 people who were underperforming across the board as part of this standard process. Even during the pandemic, when business was sluggish, we changed directions and found a new cash flow, which allowed us to keep all of our employees,” she added.
Further info revealed that GST representatives had gone to Pristyn Care’s workplace a couple of months earlier to ask questions concerning the actions of the agency. The startup’s spokesman confirmed the GST officers’ go to. “The GST division had some easy questions concerning the best way we run our enterprise. We supplied full cooperation and gave all of the required info. We have additionally given up a few of the GST enter tax credit score that was accessible to us as a part of the process (beneath protest),” the spokesperson added.
Pristyn Care is one of the many Indian startups that have shrunk their workforce in the past months. In the past two months, Peers Phable and Medibuddy fired 70% and 8% of their staff respectively.
Established in 2018, Pristyn Care offers advanced secondary surgery care through its network of over 800 hospitals, 200+ clinics and over 400 in-house super-speciality surgeon chambers. The Gurugram-based startup has raised over $177 million so far. Pristyn Care raised $96 million in its Series E round funding in December 2021 and had its 7-month valuation increase to $1.4 billion, and became the fastest-growing health tech unicorn. Lybrate, a healthcare business based in New Delhi, was purchased by it last year for an unknown sum.
Read all of the Latest Business News right here
